Liqin Liu

Liqin Liu

Company: IGM Biosciences

Job title: Senior Director of T Cell Engagers


IGM-2323 – High Avidity IgM-Based CD20xCD3 Bispecific Antibody for Enhanced T Cell Dependent Killing with Minimal Cytokine Release 11:30 am

Outlining current state of bispecific antibodies that are largely based on IgGlike scaffolds Providing provide high avidity binding to CD20, an scFv fused to the N-terminus of J-chain to provide monovalent engagement of CD3 on T-cells and HSA fused to the C-terminus of J-chain to improve pharmacokinetics Demonstrating preclinical IGM-2323 data is highly effective at…Read more

day: Focus Day Track B - AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.